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Abstract
Rapid monitoring of concentration changes of neurotransmitters and energy metabolites is 
important for understanding the biochemistry of neurological disease as well as for developing 
therapeutic options. This paper describes the development of a separation-based sensor using 
microchip electrophoresis (ME) with electrochemical (EC) detection coupled to microdialysis 
(MD) sampling for continuous on-line monitoring of adenosine and its downstream metabolites. 
The device was fabricated completely in PDMS. End-channel electrochemical detection was 
accomplished using a carbon fiber working electrode embedded in the PDMS. The separation 
conditions for adenosine, inosine, hypoxanthine, and guanosine were investigated using a ME-EC 
chip with a 5-cm long separation channel. The best resolution was achieved using a background 
electrolyte consisting of 35 mM sodium borate at pH 10, 15% dimethyl sulfoxide (DMSO), and 2 
mM sodium dodecyl sulphate (SDS), and a field strength of 222 V/cm. Under these conditions, all 
four purines were separated in less than 85 s. Using a working electrode detection potential of 1.4 
vs Ag/AgCl, the limits of detection were 25, 33, 10, and 25 μM for adenosine, inosine, 
hypoxanthine, and guanosine, respectively. The ME-EC chip was then coupled to microdialysis 
sampling using a novel all-PDMS microdialysis-microchip interface that was reversibly sealed. 
This made alignment of the working electrode with the end of the separation channel much easier 
and more reproducible than could be obtained with previous MD-ME-EC systems. The integrated 
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The adenosine family of compounds is comprised of many important biologically active 
substances, including DNA, RNA, and adenosine triphosphate (ATP), that are critical for 
many key biological pathways and are involved in several disease states.1,2 Due to their 
important role in cellular energy metabolism, neuronal signaling and neuromodulation, 
adenosine and its up- and downstream metabolites such as ATP, inosine, and hypoxanthine 
have been considered as biomarkers for cerebral ischemia, a condition commonly developed 
during traumatic brain injury and stroke.3,4 As such, significant attention has been directed 
toward monitoring their extracellular concentrations in the brain.5,6 Fast scan cyclic 
voltammetry and enzyme-modified amperometric sensors have been explored to monitor the 
extracellular concentration of adenosine,7–10 ATP,11 and hypoxanthine.12 However, these 
methods are generally capable of monitoring only one compound at a time. To better 
understand the biochemistry of brain injury and stroke, as well as to develop better 
therapeutic options, a method that is capable of simultaneous monitoring of extracellular 
concentration changes of multiple biomarkers is necessary. For adenosine and its major 
downstream metabolites, this has generally been achieved using microdialysis sampling 
followed by off-line analysis by liquid chromatography (LC) with UV detection,13,14 
fluorescence detection,15 or mass spectrometry.16
Microdialysis is a continuous sampling technique that has been widely used both in vivo and 
in vitro.17,18 Because sampling is based on analyte diffusion across a membrane, the 
dialysate sample contains only small molecules and excludes proteins. To maximize analyte 
recovery across the membrane, sampling is performed at low flow rates, typically from 0.1 
to 2 μL/min.18 However, since most conventional separation-based methods of analysis 
require several microliters (5–20) of sample, the temporal resolution that can be obtained 
using off-line analysis is generally between 5 and 30 min. In contrast, the sample 
requirements for capillary and microchip electrophoresis are in the low nanoliter to picoliter 
range, making it possible to analyze smaller sample volumes and, therefore, obtain better 
temporal resoluton.17 In addition, ME separations are significantly faster than similar 
separations performed using conventional liquid chromatography or capillary 
electrophoresis. For this reason, microchip electrophoresis is considered an excellent 
candidate for on-line near real-time analysis of microdialysis samples.
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ME has improved significantly since its introduction in the early 1990s, and is now a well-
established analytical tool in the field of separation science.19 To date, several excellent 
reviews have been published that discuss various aspects and recent developments in 
microchip electrophoresis separations.20–23 In particular, ME has been widely employed for 
biomedical applications.22,23 The planar format of ME enabled the development of 
microchip electrophoresis-based micro-total-analysis systems, where all the necessary 
components required for chemical analysis are integrated into a single device.24 The planar 
separation platform of ME also facilitates coupling of the microchip with a variety of 
detection techniques, including laser-induced fluorescence (LIF),22 mass spectrometry (MS),
25 and electrochemical detection,26 as well as sampling techniques such as microdialysis and 
push-pull perfusion.17,27 LIF is the most common detection technique employed for ME; 
however, analytes must be naturally fluorescent or be derivatized with a fluorophore in order 
to be determined by this method. Mass spectrometric detection is hampered by the high salt 
content of the electrophoresis buffer, and the instrumentation is fairly large and expensive. 
LIF and MS detection also require sophisticated optics and interfaces, respectively, for 
integration with ME separation platforms.
Electrochemical detection, particularly amperometric detection, has some distinct 
advantages over other methods of detection for ME. The instrumentation required for 
amperometric detection is relatively simple and inexpensive. Direct integration of the 
electrodes and associated electronics with ME separation systems can be accomplished 
without the use of sophisticated interfaces or optics. This feature makes it possible to 
miniaturize the ME-EC system for use in point-of-care applications or on-animal sensors.
28–30 Microdialysis coupled to ME-EC has previously been employed for continuous 
monitoring of many biologically important analytes including catecholamines and reactive 
oxygen and nitrogen species such as hydrogen peroxide and nitrite.31–33
In this paper, we report the development of a separation-based sensor for the continuous 
monitoring of adenosine and its metabolites using microdialysis sampling coupled to 
microchip electrophoresis with electrochemical detection. The ultimate goal of this study is 
to employ the sensor to continuously monitor concentration changes of adenosine and its 
metabolites in brain extracellular fluid after severe traumatic brain injury.
Materials and methods
Chemicals
The following chemicals were purchased from the designated sources and used as received: 
adenosine, inosine, hypoxanthine, guanosine, boric acid, monosodium phosphate, disodium 
phosphate and dimethylsulfoxide (Sigma Aldrich, St. Louis, MO, USA), NaOH, H2SO4, 
HCl, acetonitrile, and 2-propanol (IPA) (Fisher Scientific, Fairlawn, NJ, USA); sodium 
dodecyl sulfate (SDS) (Thermo Scientific, Waltham, MA, USA); SU-8 10 and SU-8 
developer (Micro-Chem, Newton, MA, USA); and poly(dimethyl siloxane) and curing agent 
(Sylgard 184 silicon elastomer base and curing agent, Dow Corning Corp., Midland, MI, 
USA). The 33-μm diameter carbon fibers (Avco Specialty Materials, Lowell, MA, USA), 
copper wire (22 gage. Westlake Hardware, Lawrence, KS, USA); epoxy (J-B Weld, Sulphur 
Springs, TX, USA), and colloidal silver liquid (Ted Pella, Inc., Redding, CA, USA) were 
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used for electrode preparation. Solutions were prepared in 18.2 (MΩcm) water (Millipore, 
Kansas City, MO, USA). Adenosine deaminase was purchased from Calzyme Laboratories, 
Inc. (San Luis Obispo, CA, USA) and stored in a −20 °C freezer until used.
PDMS microchips fabrication
All PDMS microchips and electrode substrates were fabricated at the Ralph N. Adams 
Institute Microfabrication Facility at the University of Kansas. A detailed description of the 
microchip fabrication procedure can be found elsewhere.34 Briefly, a 15 μm thick layer of 
SU-8 10 negative photoresist was spin coated using a Cee 100 spin coater (Brewer Science, 
Rolla, MO, USA) onto a 4-inch diameter silicon wafer. The wafer was then soft baked for 2 
min at 65 °C followed by 5 min at 95 °C. To copy the microchannel design onto the 
photoresist layer, the silicon wafer with the negative photoresist film was covered with a 
transparency mask (Infinite Graphics, Minneapolis, MN, USA) with the desired 
microchannel design and then exposed to UV (344 mJ/cm2) using a UV flood source (ABM 
Inc., Scotts Valley, CA, USA). After the photoresist was exposed to UV, the silicon master 
was baked at 65 °C for 1 min and at 95 °C for 2 min on a programmable hotplate (Thermo 
Scientific, Waltham, MA, USA). SU-8 10 developer was used to develop the silicon master, 
and it was rinsed with isopropyl alcohol and dried with N2 gas prior to hard bake at 200 °C 
for 2 h. To fabricate PDMS microchips, a mixture of PDMS and curing agent (10:1) was 
poured onto the silicon master and allowed to cure overnight at 70 °C. Once hardened, the 
PDMS microchips can be easily peeled from the silicon master. Simple ‘T’ microchips 
fabricated using this procedure consisted of a 5 cm long separation channel and 0.75 cm 
long side arms with 15 μm channel depth and 40 μm width. Double T microchips have 
exactly the same channel dimensions as simple T microchips, except that they also contain a 
600 μm wide cross channel connected to the top of the separation channel for microdialysis 
interface. Sample, buffer, and waste reservoirs were cut at the ends of the microchannels 
using a 4 mm diameter biopsy puncher (Harris Uni-Core, Ted Pella) in the PDMS chip.
Construction of reversibly sealed MD-ME interface
The procedure used for the construction of the device is shown in Figure 1. To connect the 
microdialysis probe outlet to the wider microdialysis flow channel in the double T 
microchip, a 1.5 cm long 400 μm i.d. stainless steel tube was used. To direct the MD flow to 
the separation channel, a hole (500 μm inner diameter) was made at the end of the top wide 
flow channel of the PDMS microchip. The stainless steel tube was then inserted through this 
hole to direct the microdialysis flow to the microchannel. To minimize the backpressure at 
the chip/substrate interface, the outlet of the stainless-steel tube was kept about 2 mm above 
the substrate. To secure the stainless-steel tube above the microchip surface, the tube was 
first inserted through a thick (~1 cm) PDMS block and then the PDMS block with the tube 
was permanently sealed to the chip surface using plasma oxidation (Model: BD-20, Electro-
technic Products, Inc., Chicago, IL, USA).
Integration of carbon fiber electrode on to MD-ME-EC PDMS platform
Carbon fiber microelectrodes (CF, 33 μm diameter) were integrated into PDMS substrates 
according to the procedure previously described.35 Briefly, a trench of 33 μm depth and 4 
cm length in a PDMS substrate was fabricated using the procedure described in microchips 
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fabrication section. The PDMS substrate containing the trench was sealed onto a glass plate 
to add structural rigidity. The CF was then carefully rolled into the trench. One end of the 
CF was connected to a copper wire using silver colloidal and epoxy resin to make the 
electrical contact between the CF electrode and the potentiostat. Electrode platforms 
fabricated using this procedure last for several months and can be reused with new CF as 
necessary.
Microchip electrophoresis
All the ME-EC analyses were carried out using devices with either a simple T or double T 
configuration. Spellman CZE 1000R (Hauppauge, NY, USA) high voltage power supplies 
were used for all separations, and LabView (National Instruments, Austin, TX, USA) 
software written in-house was used to control the voltage output.
Simple T microchips—For the separation optimization experiments, a simple T 
microchip was used. Microchannels were flushed sequentially with isopropyl alcohol, 0.1 M 
NaOH, and run buffer for 5 min using negative pressure (aspirator) prior to electrophoresis 
separations. SDS was added to the run buffer to maintain a stable electroosmotic flow 
(EOF). Analytes were separated using normal polarity at 222 V/cm electric field strength. 
Gated injection was used for sample introduction. This was performed by floating the high 
voltage at the buffer reservoir for 1 s.
Double T microchips—A microchip conditioning protocol similar to that described 
above was used to condition the separation channel of the double T microchip. The top 
wider channel (MD interface channel) was conditioned with only run buffer by pumping it 
through the top channel using polyimide tubing (0.127 mm ID, Index Health & Science, 
Tampa, FL, USA) connected to a syringe pump. A single high voltage power supply was 
used for the electrophoretic separation. A flow-gated sample injection method with 1900 V 
and injection time of 1.5 s was used for introduction of microdialysate to the separation 
channel.
Electrochemical detection
For both method optimization studies and on-line microdialysis sample analysis, a 3-
electrode detection system was utilized for amperometric detection. Unless otherwise 
mentioned, BAS 4C-LC Epsilon potentiostat (Bioanalytical Systems, West Lafayette, IN, 
USA) was used for the electrochemical measurements. To minimize noise, end-channel 
detection was employed. In end-channel electrochemical detection, the CF microelectrode 
was aligned 5 μm downstream of the end of the microchannel. Ag/AgCl (Bioanalytical 
Systems) and Pt wire (1 mm diameter) were used as reference and counter electrodes.
Sample preparation and on-line analysis
Stock solutions of adenosine (2.5 mM) and inosine (2.5 mM) were prepared in ultrapure 
water. The hypoxanthine (2.5 mM) and guanosine (2.5 mM) stock solutions were prepared 
in 0.06 M NaOH. All solutions were stored at 4 °C in the dark. Working standards of 
adenosine (100 μM), guanosine (100 μM), hypoxanthine (50 μM), and inosine (150 μM) 
were prepared by diluting stock solutions with the appropriate run buffer at the time of 
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analysis. All MD-ME-EC experiments were performed using homemade 3 cm linear 
microdialysis probes with 20 kDa molecular weight cut-off. The complete procedure for 
fabrication of linear MD probes can be found in reference [36].36 Briefly, two polyimide 
tubes (163 μm O.D and 122 μm I.D and lengths of 30 cm and 15 cm, Cole-Parmer, Vernon 
Hills, IL USA) were glued to a 3 cm long polyacrylonitrile (PAN) membrane. The two free 
ends of the polyimide tubes were glued to 0.5 cm long polypropylene tubes (0.5 mm O.D) to 
set up the connections to syringe pump and stainless-steel guide tube. A flow rate of 1 
μL/min was employed in all on-line experiments conducted to monitor the conversion of 
adenosine to inosine. Adenosine deaminase (ADA) enzyme was dissolved in 15 mM 
phosphate at pH 7.4, and the enzyme reaction mixture was kept in a water bath at 37 °C 




The goal of this research was to develop a method for the continuous monitoring of 
adenosine, inosine, hypoxanthine, and guanosine based on microdialysis sampling coupled 
to microchip electrophoresis with amperometric detection. Because of their role in many 
important biological processes, the direct electrochemical detection of purine-based 
compounds has gained significant attention.37–40 However, many purine-based compounds, 
including the compounds targeted in this study, are oxidized at high electrode potentials.
37,38,41 It has also been shown that the electrochemical oxidation of these compounds 
proceeds via adsorption onto an active electrode surface.37,42 Due to these considerations, 
carbon-based materials, such as glassy carbon and carbon fibers, have been used for the 
investigation of the electrochemical properties of adenosine, inosine, hypoxanthine, and 
guanosine.38,43–45 Compared to metal-based electrodes, carbon-based electrodes are inert to 
surface oxide formation and exhibit more stable background currents at high oxidation 
potentials. Based on the considerations of the sensitivity, stability, and ease of integration 
with microchip electrophoresis, a carbon fiber was chosen as the working electrode material 
for the present study. Figure 2 shows the hydrodynamic voltammograms (HDV) obtained for 
the three adenosine family compounds by ME-EC using a carbon fiber electrode with a 
sodium borate background electrolyte at pH 10. It can be seen from the HDV that the onset 
potential for the oxidation of inosine is at least 200 mV higher than that of the hypoxanthine. 
Therefore, to obtain the best sensitivity for all the analytes of interest, a potential of +1.4 V 
vs Ag/AgCl was selected as the detection potential in these studies.
Separation optimization
Separation optimization of the four purine compounds was performed using a simple T 
PDMS microchip with 5 cm long separation channel. Because of the high pKas of the 
analytes of interest (except for adenosine),46,47 sodium borate at pH 10.0 was selected as the 
background electrolyte (BGE) for initial electrophoresis separation. Under these conditions, 
it was expected that inosine, guanosine, and hypoxanthine would be negatively charged.
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Unfortunately, the use of borate alone as the BGE did not produce acceptable resolution of 
the four analytes (Figure 3A). Surprisingly, the peaks for the structurally very different 
compounds hypoxanthine and guanosine significantly overlapped at all the borate 
concentrations tested. Modification of the run buffer with common EOF modifiers, such as 
methanol and acetonitrile, did not improve resolution. However, as can be seen in Figure 3B, 
the addition of a small amount of dimethyl sulfoxide (DMSO) to the BGE improved the 
resolution significantly. This resolution enhancement can be explained by considering the 
ability of DMSO to slow the EOF as well as to disrupt interactions between water and 
anionic analytes.48 The reduction in EOF is not surprising, since DMSO increases the 
viscosity and decreases the dielectric constant of the BGE. This reduces the zeta potential of 
the channel wall.48 In addition, DMSO has a specific ability to reduce the solvation of 
anionic species by disrupting the hydrogen bonding between water and analytes, causing 
changes to the hydration radii of the analytes.48
The use of borate as the background electrolyte provided several additional important 
advantages for the separation of the four biomarkers of interest. Its relatively low 
conductivity permitted the use of high concentrations without generating excessive Joule 
heating in the PDMS microchannels. Increasing the borate concentration decreases the EOF, 
which was ultimately helpful for improving the resolution (Figure 3C). In addition to the low 
conductivity and the high buffer capacity of borate at pH 10.0, it also has a unique ability to 
form complexes with compounds containing cis diol groups.49 All the purine nucleosides 
used in this study, except hypoxanthine, possess cis diol groups and can form diol-boronate 
complexes that possess an additional negative charge over the native compound. In 
particular, this approach aided in the separation of adenosine, which is originally neutral but 
forms a negatively charged adenosine-boronate complex. Similarly, the borate complexes of 
guanosine and inosine become (–2) charged.
Using the PDMS microchip with end-channel amperometric detection, near-baseline 
resolution was achieved for the four biomarkers using a BGE consisting of 35 mM borate 
with 2 mM SDS and 15% DMSO (v/v). SDS was included in the run buffer to maintain the 
stability of the EOF in the PDMS chips. Under these conditions, the four purine compounds 
were separated in under 85 s (Figure 3D). The separation efficiencies obtained for the 
analytes were between 360,000 and 440,000 theoretical plates per meter. The limits of 
detection were 10 μM, 25 μM, 25 μM, and 33 μM for hypoxanthine, adenosine, guanosine, 
and inosine, respectively (Table 1). These values are higher than the detection limits that 
have been reported using CE-UV,50 HPLC-UV,51 and mass spectrometry.52 However, 
electrochemical detection should provide greater selectivity than UV detection for biological 
samples and is easier to implement in the microchip format for on-line monitoring. Mass 
spectrometric detection is very selective but requires expensive and relatively large 
instrumentation. This makes it more difficult to implement for near- or on-animal on-line 
monitoring applications.
On-line MD-ME-EC analysis
On-line coupling of microdialysis sampling with microchip electrophoresis was first 
reported in 2004 by Huynh et al. and has since gained significant attention in bioanalytical 
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applications.53 A stable MD-ME interface that can reproducibly introduce the sample into 
the separation channel is important for successful on-line monitoring. To date, three different 
MD-ME interfaces have been described in the literature. These are the flow-gated sample 
injection interface,31 on-chip flow splitter (segmented flow),54 and integrated pneumatic 
valve-based MD-ME interface.55,56 In the present study, a flow-gated sample injection 
interface is employed. Since flow-gated interfaces work by manipulating voltages, they are 
more amenable to remote control than the other methods and, therefore, are better suited to 
on-animal sensing applications.28
Most early applications of on-line MD-ME employed LIF detection. However, more 
recently, several electrochemical detection-based on-line MD-ME analysis platforms have 
been described.32,57 In particular, the Martin group developed a novel multilayer pneumatic 
valve-based ME platform for on-line analysis of microdialysis samples that has been 
successfully employed for on-line MD-ME analysis with electrochemical detection.55 Our 
group reported the use of an all-glass microchip device for MD-ME-EC that employed a 
flow-gated interface and integrated Pt electrodes for on-line analysis of microdialysis 
samples. This device was demonstrated for monitoring peroxide generated from enzyme 
reactions and for monitoring nitroglycerin metabolism in freely roaming sheep.28,31 More 
recently, Saylor et al. reported the use of a pyrolyzed photoresist carbon film working 
electrode (PPF) for detection of catecholamines in anesthetized rats using a PDMS/glass 
hybrid MD-ME-EC platform.33 In both of these applications, either the whole microchip or 
part of the chip was irreversibly bonded to the substrate to prevent delamination of the chip 
due to the hydrodynamic pressure generated at the chip/substrate interface by the 
microdialysis flow.
While irreversibly sealed microchips have the advantage of providing a robust MD-ME 
interface, when it comes to implementing electrochemical detection, irreversibly bonding of 
the microchip to the substrate has several disadvantages. If the channels are damaged due to 
clogging or Joule heating, the entire device has to be discarded. In addition, when the 
microchip is permanently bonded to the substrate, it is difficult to reproducibly align the 
microchannel with the electrode. Reproducible electrode-channel alignment is critical to 
obtain the best signal-to-noise ratio, applied working electrode potential, and reproducible 
detector response. To address the drawbacks associated with the use of irreversibly sealed 
devices with electrochemical detection for MD-ME-EC, a simple reversibly sealed all-
PDMS microchip device was developed for on-line analysis.
The procedure for the fabrication of the reversibly sealed device is described in detail in the 
Experimental Section. Since the microchip is reversibly sealed with the substrate containing 
the electrode, aligning the microchannel with the CF fiber was much less difficult. More 
importantly, the PDMS-CF substrate could be reused for multiple experiments. The MD-
ME-EC devices fabricated in this manner were tested at several microdialysis flow rates, and 
it was found that the device could withstand flow rates up to 5 μL/min. Typical flow rates 
used for microdialysis sampling are in the range of 0.1–2 μL/min.18 Therefore, the device 
described can be used for other MD-ME-EC applications.
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Once the stability of the new reversibly sealed MD-ME-EC platform was demonstrated, the 
device was evaluated for the continuous on-line monitoring of the enzymatic conversion of 
adenosine to inosine by adenosine deaminase. A linear microdialysis probe was used to 
sample the products generated in a 2 mL polypropylene vial containing adenosine (2.5 mM), 
adenosine deaminase (22 mg/mL), and the internal standard guanosine (2.5 mM). In these 
studies, it was possible to continuously monitor the reaction for more than 3 h without any 
chip failure. Figure 4 shows representative electropherograms recorded over the 1.5 -h 
period with the developed MD-ME-EC system. Five stacked curves—a,b,c,d, and e—
corresponding to different sampling time points of the continuous online monitoring of 
adenosine metabolites are shown in Figure 4. Figure 4a shows baseline prior to addition of 
ADA and guanosine. The electropherograms obtained following the addition of ADA and 
guanosine are shown in Figure 4b. After 20 min, the appearance of guanosine (used as the 
internal standard) is detected as shown in Figure 4c. This provides an idea of the “lag time” 
of the system due to tubing. Adenosine was then added to the vial and its appearance is 
shown Figure 4d at approximately 30 min. In the three consecutive injections shown in 
Figure 4e (starting at 40.1 min), the appearance and growth of a peak for inosine due to the 
enzymatic conversion of adenosine by adenosine deaminase is observed.
In these electropherograms, an unidentified matrix (peak 3) present in the ADA sample was 
found to co-migrate with adenosine (peak 4); thus it was not possible to quantitate adenosine 
in these studies. The first noticeable appearance of inosine (peak 2) was observed within 512 
s from the initial mixing of adenosine with the enzyme. As expected, the inosine signal 
rapidly increased within the first few minutes of the reaction and then levelled off over time 
(Figure 5). The experimental lag time, or the time from the changing concentration in the 
reaction mixture until the change was measured by the device, was about 506 s. The 
identification of the analytes was based on the migration times recorded with standards at 
the beginning of the experiment. They were further verified after the experiment using 
standard addition.
The time required to observe the first appearance of guanosine, the internal standard, was 
used to estimate the response time of the device. The response time for the device used in 
these studies was approximately 90 s or equal to a run time of a single sample injection. 
Although having the stainless-steel connector tube 2 mm above the substrate helped to 
alleviate the back-pressure at the chip/substrate interface, it is obvious that this introduces 
additional dead volume into the system. This volume was estimated to be about 0.4 μL. The 
total length of the tubing from the probe to the device used for this experiment was 
approximately 16.5 cm (3.6 μL volume). However, it is worth noting that the lag time and 
the dead volume of the device are very dependent on the length and inner diameter of the 
tubing and connections as well as the flow rate. Therefore, by varying these parameters, lag 
time and the dead volume of the device can be further optimized based on the experimental 
requirements. Furthermore, using a higher PDMS:curing agent ratio (Ex: 20:1), one could 
fabricate PDMS microchips with stronger adhesion to the substrate. This would make it 
possible to use a smaller gap between the stainless steel tube and the electrode platform.
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A microchip electrophoresis separation-based system coupled to electrochemical detection 
has been developed for simultaneous monitoring of adenosine and its major downstream 
metabolites, namely, inosine and hypoxanthine. An innovative approach to integrate 
microdialysis sampling with an all-PDMS microchip device consisting of a CF working 
electrode for amperometric detection was developed. The availability of the developed 
reversibly sealed MD-ME-EC device for long-time continuous on-line monitoring was 
successfully demonstrated using an in vitro assessment of enzymatic conversion of 
adenosine to inosine. Current research is focused on achieving lower limits of detection for 
the four purine analytes so that the system can be employed in vivo to investigate their role 
in neurodegenerative processes.
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procedure for the construction of reversibly sealed md/me platform; (1) insert stainless steel 
tube into the pdms block and permanently bond the block to the microchip; (2) reversibly 
align the separation channel with cf electrode; (3) attach microdialysis sampling outlet to the 
microchip device.
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hydrodynamic voltammograms of hypoxanthine, adenosine and inosine with end-channel 
detection at cf working electrode. bge, 35 mm sodium borate at ph 10 with 15% dmso and 2 
mm sds.
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optimization of the separation of 1) adenosine, 2) hypoxanthine, 3) guanosine and 4) inosine 
by me-ec. a) separation of the four compounds in 25 mm sodium borate at ph 10.0 with no 
dmso in the bge b) effect of dmso on separation; bge contains 25 mm sodium borate at ph 
10.0 with 2 mm sds. c) effect of borate concentration on separation; bge contains 15% dmso 
(v/v) and 2 mm sds. d) separation of the four biomarkers under optimal separation 
conditions: 35 mm borate at ph 10 with 15 % dmso (v/v) and 2 mm sds. all separations were 
studied using 5 cm separation channel at 222 cm/v field strength at end-channel detection.
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continuous on-line monitoring of enzymatic conversion of adenosine to inosine using 
reversibly sealed md-me-ec device; ‘*’ represents the time of sample injections. (a) baseline, 
(b) ada and guanosine addition, (c) appearance of guanosine peak, (d) adenosine addition, 
(e) appearance and growth of inosine peak the peak identities are (1) guanosine (internal 
standard) (2) inosine, (3) unknown in sample matrix, and (4) adenosine. a and b represent 
the times for the addition of guanosine and adenosine to the reaction mixture, respectively.
Gunawardhana and Lunte Page 16














a) time plot of the enzymatic conversion of adenosine to inosine by adenosine deaminase 
enzyme followed by md-me-ec. b) an electropherogram of a single sample injection 
extracted from the continuous electropherogram recorded for over one and half hours. the 
arrow on the time plot indicates the start of the sample injection of the electropherohram. the 
peak identities are (1) guanosine and (2) inosine.
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table 1.
figures of merit for end-channel detection; bge: 35 mm borate at ph 10 with 15% dmso and 2 mm sds (n = 3 
sample injections). where r- resolution, n- number of theoretical plates, lod- limits of detection, ldr- linear 
dynamic range
Analyte R/from previous peak N/per meter LOD/μM LDR/μM
Adenosine N/A 375,584 (± 7,345) 25 75–400
Hypoxanthine 5.97 (±0.07) 388,787 (± 7,087) 10 20–100
Guanosine 1.30 (±0.01) 441,652 (±12,551) 25 75–400
Inosine 1.39 (±0.04) 364,353 (± 12,565) 33 75–150
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